Aquinox completes patient enrollment in Phase II LEADERSHIP trial of AQX-1125 to treat BPS/IC
A total of 70 patients have been enrolled in the trial, which is examining the ability of AQX-1125 to reduce pain in female patients with BPS/IC, a chronic
The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have granted paediatric clinical trial waivers to Shanton Pharma for its lead candidate SAP-001, easing the drug’s regulatory paths to approval.
The trial, which evaluated the safety, efficacy and pharmacokinetics of Alprolix, met its primary endpoint and achieved low bleeding rates with once-weekly prophylactic dosing in children. Alprolix is
Standard chemotherapy includes paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan for patients who cannot receive platinum therapy. Cervical cancer is most commonly diagnosed in women aged between